GREY:VRTHF - Post by User
Post by
HaulJockeyon Oct 16, 2017 4:10pm
152 Views
Post# 26818489
More Likely This
More Likely ThisOctober 11, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) announces the closing of a private placement of units. Under the terms of the Private Placement Offering, the Company will be issuing 3,939,600 Units. Under the terms of the placement, each unit consists of one common share and one share purchase warrant for $0.28 per share. The Company has received $1,027,600. Each share purchase warrant will entitle the holder to acquire an additional share for $0.45 for 18 months following the Closing Date. The Company can reduce the exercise period in the event that the trading price of the Shares is $1.00 or more for a period of ten consecutive days. The Company is paying finders fees totaling 269,600 units. Proceeds from this private placement will used to advance into human trials as outlined on our May 8, 2017 News Release, and for working capital purposes.